Glenmark Pharmaceuticals Sees Surge in Put Options: 5,543 Contracts at Rs 2200 Strike

Glenmark Pharmaceuticals Ltd. has emerged as one of the most active stocks in the options market today, particularly in the put options segment. The company, operating within the Pharmaceuticals & Biotechnology industry, has seen significant trading activity in its put options with expiry set for July 31, 2025.
Notably, the put option with a strike price of Rs 2100 recorded 3,508 contracts traded, generating a turnover of Rs 288.36 lakhs, while the Rs 2200 strike price option saw even higher activity with 5,543 contracts traded and a turnover of Rs 1,104.99 lakhs. The open interest for these options stands at 1,869 and 1,401 contracts, respectively, indicating a robust interest among traders.

Currently, Glenmark's underlying stock value is Rs 2,196.1, which is approximately 4.36% away from its 52-week high of Rs 2,284.8. However, the stock has underperformed its sector by 1.17% today, with a one-day return of -1.05%. The stock has been on a downward trend, losing 1.65% over the past two days. Despite this, Glenmark is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, suggesting a mixed performance in the context of longer-term trends.

In summary, Glenmark Pharmaceuticals Ltd. is witnessing notable activity in its put options, reflecting a complex interplay of market dynamics and investor behavior.